Automation of Immunoglobulin Glycosylation Analysis

Exp Suppl. 2021:112:173-204. doi: 10.1007/978-3-030-76912-3_5.

Abstract

The development of reliable, affordable, high-resolution glycomics technologies that can be used for many samples in a high-throughput manner are essential for both the optimization of glycosylation in the biopharmaceutical industry as well as for the advancement of clinical diagnostics based on glycosylation biomarkers. We will use this chapter to review the sample preparation processes that have been used on liquid-handling robots to obtain high-quality glycomics data for both biopharmaceutical and clinical antibody samples. This will focus on glycoprotein purification, followed by glycan or glycopeptide generation, derivatization and enrichment. The use of liquid-handling robots for glycomics studies on other sample types beyond antibodies will not be discussed here. We will summarize our thoughts on the current status of the field and explore the benefits and challenges associated with developing and using automated platforms for sample preparation. Finally, the future outlook for the automation of glycomics will be discussed along with a projected impact on the field in general.

Keywords: Antibody; Automation; Glycan analysis; Glycomics; High-throughput strategies; Robotization; Sample preparation.

Publication types

  • Review

MeSH terms

  • Antibodies
  • Automation
  • Glycomics*
  • Glycosylation
  • Polysaccharides*

Substances

  • Antibodies
  • Polysaccharides